OncoInv and Healthcare Systems Mexico have joined forces to make multi cancer early detection available in Mexico. Healthcare Systems Mexico will be an exclusive distributor for OncoInv and will offer OncoSeek® as a novel means of detection of cancer in Mexico. OncoSeek® is a patient-friendly product to detect nine forms of cancer simultaneously based on a blood sample and requires no biopsy or imaging equipment.
“Healthcare Systems Mexico has chosen to work with OncoInv because we recognise the need for early detection of cancer in Mexico, and the excellent innovative solutions that OncoInv can bring to the Mexican market,” said Fernando Mendez, general director of Healthcare Systems Mexico.
A revolution in cancer diagnosis
OncoSeek® is a Machine Learning algorithm that uses a simple blood test to detect 9 high-mortality cancer types by analysing the concentration of a selected number of protein tumour markers.
The algorithm analyses the specific relations between markers and clinical factors, drastically reducing false positives when compared to the standard analysis of multiple, individually judged, protein tumour markers.
OncoSeek® has been developed by SeekIn (China, US). SeekIn has partnered with OncoInv to make its products available to as many countries as possible. To fulfil this ambition OncoInv offers the products at low cost.
About Healthcare Systems Mexico
Healthcare Systems Mexico is dedicated to the hospital industry with a focus on planning and equipping hospitals, offering trusted brands like Philips, LMT, Medisist and Welch Allyn. They specialise in the Integration of Hospital Equipment, from planning, financing and construction, patient monitoring, diagnostic equipment and connecting hospitals through hospital software. For more information, you can visit www.healthcaresystems.com.mx
About OncoInv
OncoInv is based in Houten, the Netherlands. The mission of OncoInv is to make multi-cancer early detection solutions available to as many people as possible, thus improving the outcome for patients and their families. OncoInv offers its products and services on a not-for-profit basis in Low- and Middle-Income countries to ensure high availability by minimizing the costs. OncoInv is a fully owned subsidiary of the non-profit foundation Inspire2Live. For more information, please continue your visit on www.oncoinv.org.
About SeekIn
SeekIn is a biotech company founded in early 2018 in Shenzhen, China, focusing on blood-based pan-cancer early detection utilizing -generation sequencing and Machine Learning. Since founded, SeekIn has been committed to providing cutting-edge and cost-effective solutions for cancer early detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn also developed novel molecular tests for leukaemia patients. With its proprietary technical advances, SeekIn has launched several research and clinical studies in collaboration with top-tier hospitals. SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed, and the cancer mortality rate can be reduced by 15%. For more information about SeekIn’s cutting-edge technologies and products, visit www.seekincancer.com.
About Inspire2Live
Inspire2Live is an international patient advocacy organisation operating on an international level. We are on a mission to inspire and empower patients, researchers and clinicians to work together to prevent, treat and eliminate cancer. If we all believe that healthcare should be for the benefit of patients, then we should be part of the discussion and the decision process: When about us, not without us. We achieve our goals by connecting stakeholders in the medical industrial complex and organising congresses and discovery networks. These connections have led to many initiatives which are transforming the way research and healthcare work to become more patient-centric. We operate globally in full respect of local considerations. For more information, please visit www.inspire2live.org.
